NEW WAYS TO DETECT OSTEOPOROSIS EARLY IN YOUNG WOMEN BEFORE MENOPAUSE.
DOI:
https://doi.org/10.37547/Keywords:
Premenopausal women, osteoporosis , early diagnosis , bone mineral densityAbstract
This means that just checking blood vitamin D or calcium might not show if bones are weak. The study suggests that looking at other markers and tools can help find osteoporosis early, especially in women who haven't gone through menopause yet. It’s important to check these risk factors early to keep bones healthy. Osteoporosis is a silent skeletal disease characterized by low bone mass and deterioration of bone microarchitecture, typically leading to increased fracture risk. While classically associated with postmenopausal estrogen deficiency, osteoporosis can also affect premenopausal women, especially when secondary factors such as vitamin D deficiency or endocrine disorders are present. Early diagnosis in premenopausal women is challenging because routine bone mineral density (BMD) screening is not usually performed in this age group. In this study, we analyzed data from 33 premenopausal women (mean age 44.9±2.4 years) to assess modern aspects of early detection. Femoral neck BMD (by DXA), T-score, Z-score, serum calcium, and 25-hydroxyvitamin D (cholecalciferol) were measured. Descriptive statistics (mean, SD, percentiles) are presented in Table 1.
Downloads
References
[1] Cohen A. (2017). Premenopausal Osteoporosis. Endocrinology and metabolism clinics of North America, 46(1), 117–133. https://doi.org/10.1016/j.ecl.2016.09.00Kim, S.-Y., Yoo, D.-M., Min, C., & Choi, H.-G. (2021). Association between osteoporosis and low hemoglobin levels: A nested case–control study using a national health screening cohort. International Journal of Environmental Research and Public Health, 18(16), 859, https://doi.org/10.3390/ijerph18168598
[2] Jessica Pepe, Jean-Jacques Body, Peyman Hadji, Eugene McCloskey, Christian Meier, Barbara Obermayer-Pietsch, Andrea Palermo, Elena Tsourdi, M Carola Zillikens, Bente Langdahl, Serge Ferrari, Osteoporosis in Premenopausal Women: A Clinical Narrative Review by the ECTS and the IOF, The Journal of Clinical Endocrinology & Metabolism, Volume 105, Issue 8, August 2020, Pages 2487–2506, https://doi.org/10.1210/clinem/dgaa306
[3] Ali, M., & Camacho, P. M. (2024). Workup and Management of Premenopausal Osteoporosis. Endocrinology and metabolism clinics of North America, 53(4), 597–606. https://doi.org/10.1016/j.ecl.2024.08.005
[4] Abraham, A., Cohen, A., & Shane, E. (2013). Premenopausal bone health: osteoporosis in premenopausal women. Clinical obstetrics and gynecology, 56(4), 722–729. https://doi.org/10.1097/GRF.0b013e3182a8ae55
[5] Chapurlat, R., Garnero, P., Sornay-Rendu, E. et al. Longitudinal Study of Bone Loss in Pre- and Premenopausal Women: Evidence for Bone Loss in Premenopausal Women . Osteoporos Int 11, 493–498 (2000). https://doi.org/10.1007/s001980070091
[6] Tobie J. de Villiers, Bone health and menopause: Osteoporosis prevention and treatment, Best Practice & Research Clinical Endocrinology & Metabolism, Volume 38, Issue 1, 2024, 101782, ISSN 1521-690X, https://doi.org/10.1016/j.beem.2023.10178
[7] Lu, B., Han, Q., Zhao, S. et al. Associations between hormones, metabolic markers, and bone mass in premenopausal and postmenopausal women. J Bone Miner Metab 43, 392–401 (2025). https://doi.org/10.1007/s00774-025-01595-x
[8] Kim, S. K., Hong, S.-J., Kim, G., Ban, J. Y., & Kang, S. W. (2025). Genome-wide association study of osteoporosis risk in Korean pre-menopausal women: The Korean Genome and Epidemiology Study. International Journal of Molecular Sciences, 26(17), 8177. https://doi.org/10.3390/ijms26178177
[9] Choi, Y., & Park, K. (2025). Dietary patterns and the risk of composite-defined osteoporosis in pre- and postmenopausal women: A prospective cohort study. Nutrients, 17(18), 2947. https://doi.org/10.3390/nu17182947
[10] Rotondi, A., Frescura, V., Arcuri, G., Garufi, G., Pontolillo, L., Mastrantoni, L., Di Monte, E., Maliziola, N., Fucile, M. A., Salvatori, F., Mondello, R., Poli, I., Oliva, G. R., Mongelli, G., Palazzo, A., Fabi, A., Bria, E., Tortora, G., & Orlandi, A. (2025). Bone health and endocrine therapy with ovarian function suppression in premenopausal early breast cancer: A real-life monocenter experience with denosumab. Current Oncology, 32(8), 421. https://doi.org/10.3390/curroncol32080421
[11] Saija, C., Bertuccio, M. P., Currò, M., & Caccamo, D. (2025). Influence of vitamin D status on the variability of collagen I C-telopeptide in pre- and post-menopausal healthy women. Journal of Clinical Biochemistry and Nutrition, 76(3), 311–316. https://doi.org/10.3164/jcbn.24-146
[12] Kasahara, K., Tanaka-Mizuno, S., Tsuji, S., Ohashi, M., Kasahara, M., Kawasaki, T., & Murakami, T. (2024). Pregnancy and lactation-associated osteoporosis as a major type of premenopausal osteoporosis: A retrospective cohort study based on real-world data. BMC Pregnancy and Childbirth, 24(1), 301. https://doi.org/10.1186/s12884-024-06520-0
